Integration of retifanlimab into the standard of care first-line therapy of advanced squamous anal cancer-lessons learned and open questions.
Free. We’ll email you when a new paper cites this one or any other paper you follow on JClub — at most one email a day. Every email has a one-tap unsubscribe.